These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2675195)

  • 81. In vivo voltammetry study of the modulatory action of prolactin on the mesolimbic dopaminergic system.
    Gonzalez-Mora JL; Guadalupe T; Mas M
    Brain Res Bull; 1990 Nov; 25(5):729-33. PubMed ID: 2289161
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
    Liang RZ; Wu M; Yim CC; Mogenson GJ
    Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens.
    Vezina P; Blanc G; Glowinski J; Tassin JP
    Synapse; 1994 Feb; 16(2):104-12. PubMed ID: 8197574
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Bloom FE
    Brain Res; 1982 Jan; 232(2):391-400. PubMed ID: 6322914
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Folate induced-hypermotility response after bilateral injection into the nucleus accumbens of the rat. Possible mediation through dopaminergic mechanisms.
    Stephens RL; Uretsky NJ
    Neuropharmacology; 1986 Aug; 25(8):887-96. PubMed ID: 3022181
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
    Boldry RC; Uretsky NJ
    Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The effects of long-term chronic buprenorphine treatment on the locomotor and nucleus accumbens dopamine response to acute heroin and cocaine in rats.
    Sorge RE; Stewart J
    Pharmacol Biochem Behav; 2006 Jun; 84(2):300-5. PubMed ID: 16806444
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of lithium on dopamine behavioural supersensitivity induced by rapid eye movement sleep deprivation.
    Arriaga F; Dugovic C; Wauquier A
    Neuropsychobiology; 1988; 20(1):23-7. PubMed ID: 2852779
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The effect of lithium carbonate on self-stimulating behavior in the rat.
    Ramsey TA; Mendels J; Hamilton C; Frazer A
    Life Sci I; 1972 Aug; 11(16):773-9. PubMed ID: 4570797
    [No Abstract]   [Full Text] [Related]  

  • 93. The effects of chronic lithium on the EEG and locomotor response to drug challenge in rats.
    Ehlers CL; Koob GF
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):133-42. PubMed ID: 4001429
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lithium-induced hypersensitivity to foot shock in rats and the role of 5-hydroxytryptophan.
    Harrison-Read PE; Steinberg H
    Nat New Biol; 1971 Jul; 232(30):120-1. PubMed ID: 5315100
    [No Abstract]   [Full Text] [Related]  

  • 95. The effect of prolonged lithium administration on activity, reactivity, and endurance in the rat.
    Smith DF; Smith HB
    Psychopharmacologia; 1973; 30(1):83-8. PubMed ID: 4707030
    [No Abstract]   [Full Text] [Related]  

  • 96. Mood and behavior regulation: interaction of lithium and dopaminergic system.
    Mohamadian M; Fallah H; Ghofrani-Jahromi Z; Rahimi-Danesh M; Shokouhi Qare Saadlou MS; Vaseghi S
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1339-1359. PubMed ID: 36843130
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatment.
    Zohar J; Murphy DL; Crawley JN
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):775-9. PubMed ID: 2675195
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
    Crawley JN; Stivers JA; Blumstein LK; Paul SM
    J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
    Crawley JN
    Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.